4D Molecular Therapeutics, Inc. (FDMT) › Total Assets4D Molecular Therapeutics, Inc. (FDMT) — Total AssetsAnnual figures by fiscal year, from SEC filings.2019: $58.23M2020: $288.33M2021: $353.49M2022: $261.85M2023: $339.89M2024: $560.38M2025: $566.71M$566.71M2019Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$566.71M+1.1%2024$560.38M+64.9%2023$339.89M+29.8%2022$261.85M-25.9%2021$353.49M+22.6%2020$288.33M+395.1%2019$58.23M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share